MyFinsight
Home
Blog
About
Net income (loss)
attributable to teva
-$576M
(-304.26%↓ Y/Y)
Net income (loss)
-$575M
(-303.18%↓ Y/Y)
US
$1,702M
Europe
$1,263M
Other Activities
$627M
International Markets
$550M
Income (gain) before
income taxes
-$455M
Income taxes (benefit)
$121M
Net revenues
$4,142M
Operating income (loss)
-$231M
Financial expenses, net
-$224M
Gross profit
$2,153M
Other loss (income)
$19M
Cost of sales
$1,989M
Research and development
expenses
$970M
Selling and marketing
expenses
$717M
General and
administrative expenses
$317M
Legal settlements and
loss contingencies
$230M
Other assets
impairments, restructuring...
$147M
Intangible assets
impairments
$22M
Back
Back
Income Statement
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
logo_teva-svg
source: myfinsight.com
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)